Acute pancreatitis linked to bevacizumab: A case report

Bevacizumab and Pancreatitis; an Uncommon Association

“…Although the FDA Adverse Event Reporting System database has shown 116 cases of pancreatitis related to bevacizumab use, only one published case report was found in the literature search done to the best of our ability highlighting the uniqueness of this presentation and the need for more data to establish the association. 2,3 The differences between the published case and our case has been represented in our table (Table 1). A potential mechanism for bevacizumab-associated pancreatitis could be via the anti-VEGF activity as other medications such as sorafenib that also inhibit VEGF receptors have shown an association with DIP.…”